US2019167699A1PendingUtilityA1
Prostate function support formula
Est. expiryDec 1, 2037(~11.4 yrs left)· nominal 20-yr term from priority
Inventors:Bassam Damaj
A61K 36/185A61K 9/2013A61K 36/736A61P 13/10A61P 13/08A61K 9/2095A61K 36/82A61K 9/2054A61K 31/191A61K 31/575A61K 36/889A61K 31/198A61K 31/355A61K 31/375A61K 31/01A61K 33/34A61K 33/04A61K 33/30A61K 31/4415
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides unit dosage forms and methods that are effective to improve prostate function. Such unit dosage forms and methods are useful to decrease bladder discomfort and improve urinary flow in men.
Claims
exact text as granted — not AI-modified1 . A unit dosage form suitable for oral administration in a human comprising:
300 mg±30 mg of Saw Palmetto; 450 mg±45 mg of Beta-Sitosterol; 150 mg±15 mg of Pygeum Africanum; 75 mg±7.5 mg of Green Tea extract; 15 mg±1.5 mg of Lycopene; and 30 mg±3 mg of Stinging Nettle.
2 . The unit dosage form of claim 1 that further comprises Vitamin E.
3 . The unit dosage form of claim 1 that further comprises Vitamin B-6.
4 . The unit dosage form of claim 1 that further comprises zinc as zinc gluconate.
5 . The unit dosage form of claim 1 that further comprises selenium as amino acid chelate.
6 . The unit dosage form of claim 1 that further comprises copper as copper gluconate.
7 . The unit dosage form of claim 1 that further comprises 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one.
8 . The unit dosage form of claim 1 that further comprises one or more amino acids selected from L-alanine, L-glutamic acid and glycine.
9 . The unit dosage form of claim 1 that further comprises one or more excipients selected from hydroxypropyl methylcellulose, rice concentrate, and silica.
10 . The unit dosage form of claim 1 that further comprises one or more excipients selected from gelatin, magnesium stearate, stearic acid, and microcrystalline cellulose.
11 . The unit dosage form of claim 1 that is formulated as a capsule or a tablet.
12 . A method to improve prostate function in a man in need thereof comprising administering a unit dosage form of claim 1 to the man.
13 . The method of claim 12 wherein bladder discomfort is decreased.
14 . The method of claim 12 wherein urinary flow is improved.
15 . The method of claim 12 wherein the unit dosage form is administered in the form of three capsules or tablets per day.
16 . The unit dosage form suitable for oral administration in a human of claim 1 comprising:
300 mg±15 mg of Saw Palmetto;
450 mg±22.5 mg of Beta-Sitosterol;
150 mg±7.5 mg of Pygeum Africanum;
75 mg±3.75 mg of Green Tea extract;
15 mg±0.75 mg of Lycopene; and
30 mg±1.5 mg of Stinging Nettle.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.